DalsnaFinance › IPOs › Vivos Therapeutics › IPO
Vivos Therapeutics, Inc. completed its initial public offering on NASDAQ on December 11, 2020, pricing at $6.00 a share.
| Ticker | VVOS |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | December 11, 2020 |
| Offering price | $6.00 |
| Shares offered | 3,500,000 |
| Total raised | $21M |
Vivos Therapeutics, Inc. sold 3,500,000 shares at $6.00 each on NASDAQ. Multiplied out, that is $21 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $21 million total recorded for the deal.
Vivos Therapeutics, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Vivos Therapeutics, Inc.. This page is general information, not investment advice.